Filing metadata

Accession number
0000950170-24-028171
Form type
Form 4
Filer
Ambrx Biopharma, Inc.
CIK
CIK 1990550
Filed
Mar 07, 2024
Reporting period
Mar 07, 2024
Description
Insider transaction

Explore SEC Filings Hub